Stifel Financial’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,518
| Closed | -$17.9K | – | 3587 |
|
2025
Q1 | $17.9K | Sell |
2,518
-2
| -0.1% | -$14 | ﹤0.01% | 3396 |
|
2024
Q4 | $55.5K | Sell |
2,520
-1,562
| -38% | -$34.4K | ﹤0.01% | 3306 |
|
2024
Q3 | $82K | Sell |
4,082
-1,394
| -25% | -$28K | ﹤0.01% | 3266 |
|
2024
Q2 | $95.3K | Buy |
5,476
+2,602
| +91% | +$45.3K | ﹤0.01% | 3221 |
|
2024
Q1 | $120K | Sell |
2,874
-141
| -5% | -$5.88K | ﹤0.01% | 3175 |
|
2023
Q4 | $75.8K | Buy |
3,015
+339
| +13% | +$8.53K | ﹤0.01% | 3189 |
|
2023
Q3 | $87.5K | Sell |
2,676
-35
| -1% | -$1.15K | ﹤0.01% | 3131 |
|
2023
Q2 | $158K | Sell |
2,711
-406
| -13% | -$23.6K | ﹤0.01% | 3094 |
|
2023
Q1 | $81.3K | Buy |
3,117
+384
| +14% | +$10K | ﹤0.01% | 3203 |
|
2022
Q4 | $81.4K | Buy |
2,733
+489
| +22% | +$14.6K | ﹤0.01% | 3156 |
|
2022
Q3 | $115K | Sell |
2,244
-5
| -0.2% | -$256 | ﹤0.01% | 3090 |
|
2022
Q2 | $65K | Sell |
2,249
-71
| -3% | -$2.05K | ﹤0.01% | 3206 |
|
2022
Q1 | $122K | Buy |
+2,320
| New | +$122K | ﹤0.01% | 3233 |
|